About Oragenics Inc. (OGEN) data
Data as of September 30, 2026.
Oragenics Inc. (OGEN) has 841.63K shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 4.35% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 24.89 days (days to cover).
Frequently asked questions
What is the current short interest in OGEN?
As of the latest FINRA settlement dated September 30, 2026, OGEN had approximately 841,634 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short OGEN?
The latest borrow fee (cost to borrow) for OGEN is 36.91% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for OGEN?
Days to cover for OGEN is approximately 24.89 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
How many OGEN shares failed to deliver?
On September 30, 2026, the latest settlement date in the SEC's fails-to-deliver data, 7 shares of OGEN had failed to deliver, worth about $3.36 at the prior day's close (under 0.01% of shares outstanding). That is the balance still outstanding that day, not new fails. Fails come from long sales and delivery delays as well as short sales.
Is OGEN a short squeeze candidate?
A squeeze needs shorts that are hard to close. OGEN trades about 33,814 shares a day and would take roughly 24.89 days to unwind current short positions, at a current borrow fee of 36.91%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.